生物技术与制药领域的最新动态
AI-based Digital Pathology Market Intelligence Report, 2025-2035, Featuring Aiforia Technologies, Ibex Medical Analytics, Indica Labs, PathAI, Roche, Visiopharm and Many Other Key Players - ResearchAndMarkets.com - The AI Journal
Emerson and Roche Collaborate on Digital Modality Library for Pharmaceutical Development - Automation World
Gilead's herpes deal; FDA approvals for Boehringer, Roche
Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma - Medical Dialogues
ROG.SW News Today: Trump Drug Plan Boosts Roche Stock on December 22 - Meyka
Roche and Novartis close to price agreement with Trump - medwatch.com
Roche hails giredestrant effect in ER-positive early-stage breast cancer - The Pharma Letter
Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial
#SABCS25: Roche’s breast cancer pill cuts post-surgery disease recurrence risk by 30%
Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial - Fierce Biotech
Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche’s Flatiron
Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche's Flatiron - Fierce Biotech
Bio/Pharmaceutical Outsourcing Report, October 2025 - Pfizer and Roche Place $10 Billion Bets on Obesity and Liver Disease Therapies as Trump Tightens Grip on Drug Pricing and Manufacturing - Yahoo Finance
Global insights on scaling and integrating digital health - Roche
Paradigm Health, seeking to use AI to enroll clinical trials, partners with Roche - statnews.com
Clinical trials tech startup Paradigm raises $78M, acquires part of Roche’s Flatiron - Endpoints News
Clinical trials tech startup Paradigm raises $78M, acquires part of Roche’s Flatiron
Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge
YuviTal wins Roche-backed breast cancer innovation challenge - JNS.org
Roche: Despite Some Study Setbacks, Pipeline Gives Me Increasing Confidence (RHHBY) - Seeking Alpha